COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01630018
Brief Title: Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial

First Submitted : March 6, 2012
First Submitted that Met QC Criteria : June 26, 2012
First Posted : June 28, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : September 20, 2016
Last Update Posted : September 22, 2016 (Estimate)